Viral Hepatitis and Liver Care
The U.S. Department of Health & Human Services (HHS) reports that between 2014 and 2018:
- the rate of new hepatitis A cases increased by 850%
- the rate of acute hepatitis B increased by 11%
- the rate of acute hepatitis C cases increased by 71%.
The same report identifies higher rates of substance use disorder, injection drug use and homelessness as factors in the increase.
According to the Centers for Disease Control and Prevention (CDC) chronic liver disease and cirrhosis were the ninth leading cause of death in the state of Idaho in 2019.
Treatment for viral hepatitis and other liver disorders can be effectively delivered by primary care clinicians with appropriate training and guidance. By learning how to identify and treat these diseases, you can help your patients avoid complications such as cirrhosis and hepatocellular carcinoma (HCC) and help prevent the spread of viral hepatitis.
Led by a panel of subject matter experts in family medicine, hepatology, gastroenterology, pharmacology and HIV care, our series will help build your confidence as you learn and develop best practices for managing liver care.
Participating also helps you connect with peers around the state to identify approaches and resources for advancing patient care and receive insightful feedback on patient cases. These sessions are designed to be collaborative, engaging and immediately applicable to your practice.
Virtual sessions for this series meet second and fourth Mondays.
Noon to 1 p.m. Mountain time
ECHO Idaho's full series schedule is available here.
The target audience is primary care providers (MD, DO, PA, NP, RN, etc.), but all clinicians are welcome.
Participation in ECHO Idaho is free for clinicians and organizations.
Please register here for the ongoing sessions.
Once you register, you’ll receive convenient, day-of Zoom access direct to your inbox – join us as your schedule allows.
Not a fan of emails? Sign up for day-of reminder texts for this session.
- Professional Development: Participants gain new skills and competencies for managing patients.
- Creating Community: Clinician teams can increase professional satisfaction and decrease isolation, thus creating a sense of community.
- Increased Patient Satisfaction: Patients can continue to work with their trusted clinician instead of traveling long distances to be seen by a specialist.
- Improved Quality of Care: Healthcare professionals who participate in ECHO increase their knowledge and self-efficacy.
- No-Cost Accredited Continuing Education: ECHO Idaho offers free accredited continuing education credits (CE). CE credit is available for participating in live sessions only, not for watching recorded sessions. To learn about a session's CE offerings, claim CE and provide feedback, please log in to Eeds. To learn more about the University of Idaho, WWAMI’s continuing education accreditation and offerings, visit our CE webpage.
ECHO Idaho is led by the University of Idaho and the WWAMI Medical Education Program.
Hepatitis C Facts
Hepatitis C is a leading cause of chronic liver disease and liver-related mortality.
- Between 2014 and 2018, acute hepatitis C cases increased 71% nationwide, with two-thirds of cases occurring among persons aged 20–39 years, the age-group most impacted by the opioid crisis.
- Because the disease can develop without symptom onset, it’s estimated that only 60% of people living with hepatitis C are aware of their status.
- Screening rates remain low in rural areas throughout Idaho, despite the fact that the CDC encourages all adults to be screened for the disease at least once and cites significant improvement in patient outcomes when the disease is diagnosed and treated early.